Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5(TM) Topical Hemostat
Stock Information for Arch Therapeutics Inc
Loading
Please wait while we load your information from QuoteMedia.